blog

LILETTA® levonorgestrel-releasing intrauterine system now FDA-approved for use for up to 6 years
Post written by Yadurshini Raveendran, FHI 360 Medicines360 and Allergan announced the U.S. Food and Drug Administration (FDA) approved the extension of LILETTA® (levonorgestrel-releasing i... Read full article
blog

When are commodities not just “commodities”?
Post written by Mukul Taparia, Managing Director, Pregna International “Commodity” is a term commonly used by our community to refer to a vast range of products, from contraceptives and ... Read full article
blog

The Initiative for Multipurpose Prevention Technologies (IMPT) Ten-Year Retrospective Report
Post written by Tishina Okegbe, FHI 360 Imagine using one product or method to safeguard against an unwanted pregnancy or a sexually transmitted infection. Well, there’s a technology for t... Read full article
blog

Pressing Pause on Your Fertility: Contraception via Egg Hibernation
Post written by Tishina Okegbe, FHI 360 Women currently have several methods of reversible contraception to choose from, including hormonal options such as the implant, injectables and pills... Read full article
blog

The Demographic and Health Surveys (DHS) Program Updates Questionnaires
The Demographic and Health Surveys (DHS) Program has updated its questionnaires for DHS-8. Since 1984, the DHS Program has provided technical assistance to more than 400 surveys in 90 countr... Read full article
blog

NICHD Releases Five-Year Strategic Plan
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has publicly released its updated five-year Strategic Plan. This strategic plan was developed th... Read full article
blog

Will Diaphragms Make A Comeback?
For hundreds of years, women have used diaphragm-like devices to shield their cervixes from sperm. As early as the 14th century, women in ancient Egypt inserted carved-out lemon halves in th... Read full article
blog

A New Frontier in Self-Care?: Self-Removal Options for Long-Acting Contraceptives
While access to family planning is increasing around the world, equitable and timely access to removal services for long-acting and reversible contraceptives (LARCs) is still a challenge. Th... Read full article
blog

Self-Care and SRH: Developing Products that Women Can Self-Administer
The development of new contraceptive technologies with the potential for self-administration is central to advancing self-care in sexual and reproductive health. However, developers must tak... Read full article
blog

Call for Comment Submissions on FDA Draft Guidance for Clinical Trials of Contraceptives
On July 11, the U.S. Food and Drug Administration (FDA) issued new draft guidance entitled “Establishing Effectiveness and Safety for Hormonal Drug Products Intended to Prevent Pregnancy... Read full article
blog

Three Funding Opportunity Announcements from the NIH
The National Institutes of Health (NIH) and the National Institute of Child Health and Human Development (NICHD) have three new funding opportunity announcements pertaining to contracepti... Read full article
blog

Rebuilding Incentives for Research and Development of Medicines
On July 11, 2019 the U.N. Human Rights Council (HRC) adopted a new resolution that had sparked debate about how to "delink" research and development (R&D) incentivization from patent systems... Read full article